- Home
- POWL vs PTGX Comparison
POWL vs PTGX Comparison
Compare POWL & PTGX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- POWL
- PTGX
- Stock Information
- Founded
- POWL 1947
- PTGX 2006
- Country
- POWL United States
- PTGX United States
- Employees
- POWL N/A
- PTGX N/A
- Industry
- POWL Electrical Products
- PTGX Biotechnology: Pharmaceutical Preparations
- Sector
- POWL Energy
- PTGX Health Care
- Exchange
- POWL Nasdaq
- PTGX Nasdaq
- Market Cap
- POWL 2.8B
- PTGX 2.7B
- IPO Year
- POWL N/A
- PTGX 2016
- Fundamental
- Price
- POWL $261.34
- PTGX $36.82
- Analyst Decision
- POWL Strong Buy
- PTGX Strong Buy
- Analyst Count
- POWL 1
- PTGX 8
- Target Price
- POWL $312.00
- PTGX $54.63
- AVG Volume (30 Days)
- POWL 437.1K
- PTGX 660.4K
- Earning Date
- POWL 01-28-2025
- PTGX 02-25-2025
- Dividend Yield
- POWL 0.41%
- PTGX N/A
- EPS Growth
- POWL 173.11
- PTGX N/A
- EPS
- POWL 12.29
- PTGX 2.68
- Revenue
- POWL $1,012,356,000.00
- PTGX $323,795,000.00
- Revenue This Year
- POWL $12.02
- PTGX $441.08
- Revenue Next Year
- POWL $5.47
- PTGX N/A
- P/E Ratio
- POWL $21.26
- PTGX $13.72
- Revenue Growth
- POWL 44.77
- PTGX 125.73
- 52 Week Low
- POWL $76.29
- PTGX $23.89
- 52 Week High
- POWL $364.98
- PTGX $48.89
- Technical
- Relative Strength Index (RSI)
- POWL 57.02
- PTGX 39.62
- Support Level
- POWL $218.00
- PTGX $35.03
- Resistance Level
- POWL $262.24
- PTGX $40.07
- Average True Range (ATR)
- POWL 11.29
- PTGX 1.56
- MACD
- POWL 4.42
- PTGX -0.04
- Stochastic Oscillator
- POWL 97.35
- PTGX 34.89
About POWL Powell Industries Inc.
Powell Industries Inc is a United States-based company that develops, designs, manufactures, and services custom-engineered equipment and systems for electrical energy distribution, control, and monitoring. The company's principal products comprise integrated power control room substations, custom-engineered modules, electrical houses, traditional and arc-resistant distribution switchgear and control gear, and so on. These products are applied in oil and gas refining, offshore oil and gas production, petrochemical, pipeline, terminal, mining and metals, light-rail traction power, electric utility, pulp and paper, and other heavy industrial markets. The company generates the majority of its sales from the United States, and the rest from Canada, Europe, Asia Pacific, and other regions.
About PTGX Protagonist Therapeutics Inc.
Protagonist Therapeutics Inc is a clinical-stage biopharmaceutical company having a proprietary technology platform that enables the discovery and development of novel constrained peptide-based drug candidates to address medical needs. Its pipeline products include Rusfertide (PTG-300) and JNJ-2113.